First Patient Dosed in New Study Investigating Novel Made-In-Canada Drug Candidate to Prevent Brain Injury in Hemodialysis Patients

TORONTO--(BUSINESS WIRE)-- #Hemodialysis--Study Will Investigate Pegevongitide's Ability to Prevent Acute Brain Injury in the Uniquely Vulnerable Hemodialysis Patient Population